Medical research

Putting the brakes on immune reactions

When we are exposed to a pathogen, the immune system's B cells swarm to our lymph nodes, spleens, and tonsils. There, those cells mutate in germinal centers—microscopic boot camps that rush the B cells through volleys of ...

Vaccination

EXPLAINER: Are we going to need COVID-19 booster shots?

Just because Pfizer wants to offer COVID-19 vaccine boosters doesn't mean people will be lining up anytime soon—U.S. and international health authorities say that for now, the fully vaccinated seem well protected.

Vaccination

COVID-19 vaccine boosters: Is a third dose really needed?

The UK is enjoying real success with its COVID-19 vaccine coverage. Around 85% of adults (44.8 million people) have received one vaccine dose and 63% (33 million people) both doses, with around 160,000 doses a day still being ...

Oncology & Cancer

Scientists trial new way to boost CAR T-cell therapy

Cancer Research UK is collaborating with Aleta Biotherapeutics (Aleta) to trial a new therapy that 'reboots' a treatment for some people with blood cancer whose cancer starts to come back.

Oncology & Cancer

New health benefits of red seaweeds unveiled

Red seaweeds have been prevalent in the diets of Asian communities for thousands of years. In a new study, published in Marine Drugs, researchers have shown how these algae confer health benefits.

Immunology

Vaccines charge up natural immunity against SARS-CoV-2

According to new research, people who have had COVID enjoy strong immunity against the coronavirus for at least a year after they were initially infected. In analyzing antibodies present in the blood of COVID patients, Rockefeller ...

Immunology

Vaccine efficacy is a 'gut reaction'

Varying immune response to vaccinations could be countered with microbiota-targeted interventions helping infants, older people and others to take full advantage of the benefits of effective vaccines, Australian and US experts ...

page 29 from 40